These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33567866)

  • 1. Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden.CETP Mice.
    Zhou E; Li Z; Nakashima H; Liu C; Ying Z; Foks AC; Berbée JFP; van Dijk KW; Rensen PCN; Wang Y
    Arterioscler Thromb Vasc Biol; 2021 Apr; 41(4):1474-1486. PubMed ID: 33567866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development.
    Zhou E; Hoeke G; Li Z; Eibergen AC; Schonk AW; Koehorst M; Boverhof R; Havinga R; Kuipers F; Coskun T; Boon MR; Groen AK; Rensen PCN; Berbée JFP; Wang Y
    Cardiovasc Res; 2020 Aug; 116(10):1710-1720. PubMed ID: 31589318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of brown fat activation on top of PCSK9 inhibition with alirocumab on dyslipidemia and atherosclerosis development in APOE*3-Leiden.CETP mice.
    Zhou E; Li Z; Nakashima H; Choukoud A; Kooijman S; Berbée JFP; Rensen PCN; Wang Y
    Pharmacol Res; 2021 May; 167():105524. PubMed ID: 33667684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
    Liu C; Schönke M; Zhou E; Li Z; Kooijman S; Boon MR; Larsson M; Wallenius K; Dekker N; Barlind L; Peng XR; Wang Y; Rensen PCN
    Cardiovasc Res; 2022 Jan; 118(2):489-502. PubMed ID: 33693480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
    Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary choline increases brown adipose tissue activation markers and improves cholesterol metabolism in female APOE*3-Leiden.CETP mice.
    Liu C; Song Z; Li Z; Boon MR; Schönke M; Rensen PCN; Wang Y
    Int J Obes (Lond); 2023 Mar; 47(3):236-243. PubMed ID: 36732416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.
    Zhou H; Li Z; Silver DL; Jiang XC
    Biochim Biophys Acta; 2006 Dec; 1761(12):1482-8. PubMed ID: 17055779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.
    Hoeke G; Wang Y; van Dam AD; Mol IM; Gart E; Klop HG; van den Berg SM; Pieterman EH; Princen HMG; Groen AK; Rensen PCN; Berbée JFP; Boon MR
    Atherosclerosis; 2017 Dec; 267():116-126. PubMed ID: 29121499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice.
    van Eenige R; Ying Z; Tambyrajah L; Pronk ACM; Blomberg N; Giera M; Wang Y; Coskun T; van der Stelt M; Rensen PCN; Kooijman S
    J Lipid Res; 2021; 62():100070. PubMed ID: 33766515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.
    Wang Y; Parlevliet ET; Geerling JJ; van der Tuin SJ; Zhang H; Bieghs V; Jawad AH; Shiri-Sverdlov R; Bot I; de Jager SC; Havekes LM; Romijn JA; Willems van Dijk K; Rensen PC
    Br J Pharmacol; 2014 Feb; 171(3):723-34. PubMed ID: 24490861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
    van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids.
    Tadin-Strapps M; Peterson LB; Cumiskey AM; Rosa RL; Mendoza VH; Castro-Perez J; Puig O; Zhang L; Strapps WR; Yendluri S; Andrews L; Pickering V; Rice J; Luo L; Chen Z; Tep S; Ason B; Somers EP; Sachs AB; Bartz SR; Tian J; Chin J; Hubbard BK; Wong KK; Mitnaul LJ
    J Lipid Res; 2011 Jun; 52(6):1084-1097. PubMed ID: 21398511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice.
    Auvinen HE; Wang Y; Princen H; Romijn JA; Havekes LM; Smit JW; Meijer OC; Biermasz NR; Rensen PC; Pereira AM
    PLoS One; 2013; 8(5):e63882. PubMed ID: 23717502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of Phospholipid Transfer Protein-Mediated High-Density Lipoprotein Maturation Reduces Scavenger Receptor BI Deficiency-Driven Atherosclerosis Susceptibility Despite Unexpected Metabolic Complications.
    Hoekstra M; van der Sluis RJ; Hildebrand RB; Lammers B; Zhao Y; Praticò D; van Berkel TJC; Rensen PCN; Kooijman S; Jauhiainen M; van Eck M
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):611-623. PubMed ID: 31941380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesteryl ester transfer protein (CETP) expression protects against diet induced atherosclerosis in SR-BI deficient mice.
    Harder C; Lau P; Meng A; Whitman SC; McPherson R
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):858-64. PubMed ID: 17272756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of cholesteryl ester transfer protein (CETP): attenuation of adiposity by enhancing lipolysis and brown adipose tissue activity.
    Raposo HF; Forsythe P; Chausse B; Castelli JZ; Moraes-Vieira PM; Nunes VS; Oliveira HCF
    Metabolism; 2021 Jan; 114():154429. PubMed ID: 33166579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein).
    Rautureau Y; Deschambault V; Higgins MÈ; Rivas D; Mecteau M; Geoffroy P; Miquel G; Uy K; Sanchez R; Lavoie V; Brand G; Nault A; Williams PM; Suarez ML; Merlet N; Lapointe L; Duquette N; Gillis MA; Samami S; Mayer G; Pouliot P; Raignault A; Maafi F; Brodeur MR; Levesque S; Guertin MC; Dubé MP; Thorin É; Rhainds D; Rhéaume É; Tardif JC
    Circulation; 2018 Oct; 138(16):1677-1692. PubMed ID: 29674325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PXR agonism decreases plasma HDL levels in ApoE3-Leiden.CETP mice.
    de Haan W; de Vries-van der Weij J; Mol IM; Hoekstra M; Romijn JA; Jukema JW; Havekes LM; Princen HM; Rensen PC
    Biochim Biophys Acta; 2009 Mar; 1791(3):191-7. PubMed ID: 19150509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.